A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors'

被引：0
|
作者：
Kakolyris
机构：
来源：
ONCOLOGY | 2006年 / 71卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors
    Kakolyris, S
    Kouroussis, C
    Koukourakis, M
    Marvroudis, D
    Malas, K
    Vardakis, N
    Bozionelou, V
    Kalbakis, K
    Georgoulias, V
    ONCOLOGY, 2002, 63 (03) : 213 - 218
  • [2] A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors
    Mavroudis, D
    Pappas, P
    Kouroussis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Androulakis, N
    Souglakos, J
    Vardakis, N
    Nikolaidou, M
    Samonis, G
    Marselos, M
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 304 - 312
  • [3] A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumors
    Kotsakis, A.
    Kouroussis, Ch.
    Androulakis, N.
    Agelaki, S.
    Kalbakis, K.
    Vamvakas, L.
    Vardakis, N.
    Kalykaki, A.
    Polyzos, A.
    Georgoulias, V.
    Mavroudis, D.
    ONCOLOGY, 2006, 71 (3-4) : 190 - 196
  • [4] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Capecitabine (Xeloda®) in combination with oxaliplatin:: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors
    Díaz-Rubio, E
    Evans, TRJ
    Tabernero, J
    Cassidy, J
    Sastre, J
    Eatock, M
    Bisset, D
    Regueiro, P
    Baselga, J
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 558 - 565
  • [6] Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors
    Kakolyris, S
    Souglakos, J
    Kouroussi, C
    Androulakis, N
    Samonis, G
    Vardakis, N
    Amarantidis, K
    Agelaki, S
    Mavroudis, D
    Xenidis, N
    Georgoulias, V
    ONCOLOGY, 2004, 66 (04) : 253 - 259
  • [7] Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
    Cao, Junning
    Ji, Dongmei
    Chen, Zhiyu
    Shen, Weina
    Wang, Jin
    Li, Baoyue
    Chi, Haidong
    Long, Amanda
    Gao, Ling
    Li, Jin
    ONCOLOGIST, 2017, 22 (06): : 638 - +
  • [8] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [9] Final results of a phase I dose-escalation study of ON 01910.Na in combination with oxaliplatin in patients with advanced solid tumors
    Ohnuma, T.
    Holland, J. F.
    Goel, S.
    Wilck, E.
    Lehrer, D.
    Ghalib, M. H.
    Chaudhary, I.
    Wilhelm, F.
    Swami, U.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors
    Saridaki, Zacharenia
    Bozionelou, Vasiliki
    Kentepozidis, Nikolaos
    Kotsakis, Athanasios
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Gioulbasanis, Ioannis
    Karabeazis, Athanasios
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    ONCOLOGY, 2007, 72 (1-2) : 45 - 50
12345